Oral decontamination with chlorhexidine reduced ventilator-associated pneumonia in high-risk patients

November 2006
ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p68
Academic Journal
The article presents information on a medical study that finds the effects of oral decontamination with chlorhexidine on ventilator-associated pneumonia in high-risk patients. The study was carried out on 385 patients aging less than 18 years requiring mechanical ventilation for 48 hours. The study revealed that the oral decontamination was helpful in reducing the incidence of ventilator-associated pneumonia.


Related Articles

  • Low Nurse-to-Patient Ratio May Increase Risk of Late-Onset VAP.  // Pulmonary Reviews;Sep2007, Vol. 12 Issue 9, p31 

    The article discusses research being done on the association between nurse-to-patient ratio and ventilator-associated pneumonia (VAP). It references a study by Stéphane Hugonnet and colleagues published in the July 19, 2007 online issue of "Critical Care." It details the study which found...

  • Oral decontamination with chlorhexidine reduced ventilator associated pneumonia in patients needing mechanical ventilation for ≥ 48 hours. Ee Yuee Chan // Evidence Based Nursing;Jan2007, Vol. 10 Issue 1, p19 

    The article discusses a research on the capability of oral decontamination with chlorhexidine (CHX) to reduce ventilator-associated ammonia. Results of the study showed lower incidences of ventilator-associated ammonia among patients in the CHX or CHX plus colistin group compared to patients in...

  • Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia. Gibot, Sébastien; Cravoisy, Aurélie; Levy, Bruno; Bene, Marie-Christine; Faure, Gilbert; Bollaert, Pierre-Edouard // New England Journal of Medicine;1/29/2004, Vol. 350 Issue 5, p451 

    Background: The diagnosis and treatment of bacterial pneumonia in patients who are receiving mechanical ventilation remain a difficult challenge. The triggering receptor expressed on myeloid cells (TREM-1) is a member of the immunoglobulin superfamily, and its expression on phagocytes is...

  • Ventilator-associated pneumonia, liver disease and oral chlorhexidine. Oshodi, Titilayo O.; Bench, Suzanne // British Journal of Nursing;7/13/2013, Vol. 22 Issue 13, p751 

    As part of the ventilator care bundle, the Department of Health (DH) in the UK recommends the use of chlorhexidine (CHX) for oral care to prevent the occurrence of ventilator-associated pneumonia (VAP) in all mechanically ventilated patients. Due to the heterogenous nature of this population,...

  • Diagnosing Ventilator-Associated Pneumonia. Torres, Antoni; Ewig, Santiago // New England Journal of Medicine;1/29/2004, Vol. 350 Issue 5, p433 

    Reports on how the establishment of an appropriate diagnosis of ventilator-associated pneumonia is one of the most crucial and difficult issues in the care of critically ill patients. Dangers in the postponement by physicians in making a diagnosis and starting treatment.

  • How the Use of Bundles Improves Reliability, Quality and Safety. Litch, Bonnie // Healthcare Executive;Mar/Apr2007, Vol. 22 Issue 2, p12 

    The article discusses the use of bundles in improving reliability, quality, and patient safety at Baptist Memorial Hospital-DeSoto in Southaven, Mississippi. Bundle is defined as a group of precautionary steps that when executed collectively has a positive effect on patient outcomes. Bundling...

  • Respiratory Infections.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 4, p98 

    The article presents abstracts related to respiratory infections which include the use of silver-coated endotracheal tubes to treat ventilator-associated pneumonia (VAP), the benefits of flu vaccination on elderly individuals and the increased cases of tuberculosis (TB) cases occurred in...

  • Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Seligman, Renato; Papassotiriou, Jana; Morgenthaler, Nils; Meisner, Michael; Teixeira, Paulo // Intensive Care Medicine;Nov2008, Vol. 34 Issue 11, p2084 

    This study aimed to investigate the correlation of midregional pro-atrial natriuretic peptide (MR-proANP) with severity of septic status in patients with ventilator-associated pneumonia (VAP) and the usefulness of MR-proANP for mortality prediction in VAP. Prospective observational cohort study....

  • Ventilator-associated pneumonia or bacterial colonization of the airway, what do probiotics decrease? Saptharishi, L.; Baalaaji, M.; Singhi, Sunit // Intensive Care Medicine;Jun2015, Vol. 41 Issue 6, p1161 

    A letter to the editor is presented in response to a study which proposed an affordable and novel therapy for ventilator-associated pneumonia (VAP) reduction, published online on May 14, 2015.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics